Reduce the appearance of hyperpigmentation in under 6 weeks

Offer your clients transformative results with Dermalogica PRO’s new melanopro peel system, the first 2-phased clinical strength program that fades all forms of hyperpigmentation on all skin types in less than 6 weeks.

Does your clinic offer comprehensive options to target all forms of hyperpigmentation on all skin tones, and with minimal downtime and disruption to your patients’ daily lives? While hyperpigmentation treatments, including peels, IPL and lasers, have boomed in the past 10 years, many are either not strong enough or can trigger unwanted reactions – especially among people with darker skin tones.

melanopro peel system by dermalogica PRO

Dermalogica PRO’s Melanopro Peel System fills this gap, especially for darker Fitzpatrick types and skins prone to PIH.

Melanopro is a clinical-strength peel program that delivers visible results in less than 6 weeks. This transformative 2-phase regimen works to visibly counteract environmental skin damage – fading dark spots, reducing the appearance of hyperpigmentation, and smoothing skin texture to reveal fresh, brighter skin.

Melanopro offers little to no downtime and an effective and efficient alternative to traditional hyperpigmentation treatment. The patient comes to the clinic for the initial peel and the rest of the program is done from home. The skin usually peels between days 3 and 7, after which the skin’s appearance starts to improve each day over the course of the 6-week treatment.

The in-clinic peel and at-home products include a rich and comprehensive complex of ingredients that have been developed to support resurfacing, help reduce the appearance of future dark spots, and brighten uneven skin tone. The complex includes azelaic acid, glycolic acid, lactic acid, salicylic acid, tranexamic acid, retinol, phytic acid and niacinamide.

The system can be used alone, or paired within a treatment plan that may include other skin technologies such as chemical peels, lasers, IPL, micro-needling and dermaplaning.

Melanopro Peel System does more than enhance your professional offering on all hyperpigmentation concerns – it is also highly profitable. Its competitive pricing makes depigmentation treatments accessible to a wider range of people, and encourages them to become repeat clients.

Clinical study summary

A clinical study* of topical treatment with Melanopro Peel System during 6 weeks demonstrated brightening, and smoothing capabilities, substantiated in statistically significant improvement of dark spots and homogeneity parameters, together with a significant improvement in global brightness, and a significant reduction of surface roughness, compared to baseline values before the start of the treatment.

Dark spot reduction

The topical application of Melanopro Peel System significantly reduced the total number and area of dark spots by 9.7% and 14.4% respectively, after 6 weeks of topical treatment, compared with baseline values before the start (D0).

Results also indicated a statistically significant increase in skin homogeneity between dark spots area and normal skin by 9.8% and a significant reduction of skin contrast by 9.2%, compared to D0.

Skin brightness

With regard to global brightness assessment, data indicated the treatment with Melanopro Peel System yielded a significant increase of specular brightness by 28.6% and a significant reduction of diffuse brightness by 35.1%, compared to baseline values at D0. Consistently, results indicated a non-significant increase of global brightness by 5.3%, whereas a significant but not very relevant effect was observed for skin lightness by 2.5%.

Roughness

For the analysis of surface roughness, results indicated a reduction of Stm, Sa, and Sq parameters by 14.1%, 12.9%, and 13.0%, respectively, compared to D0.

Comprehensive in-clinic and at-home offering for the modern aesthetic clinic

Dermalogica PRO’s full suite of professional formulas are designed for use alongside medical device technology. The extensive, fully customisable range can be combined with in-demand clinical treatments including laser, radiofrequency microneedling, IPL and injectables.

By partnering with Dermalogica PRO, you can be confident you are offering your patients efficacious treatments and products with proven results. AMP

Take clinical procedures to the next level with Dermalogica PRO

  • World-renowned reputation for trusted products, advanced treatments and expert skin therapists
  • Developed by skincare professionals for skincare professionals
  • Award-winning education with thorough clinician training to support business growth and development
  • Cutting edge R&D laboratory in Los Angeles led by leading doctors, chemists and skin health experts
  • Powerful, proven formulas
  • Exclusive professional-only product line
  • Highly customisable to suit each client’s skin concerns
  • Works in synergy with most in-clinic modalities
  • Competitively priced
MelanoPro

2-Phased Transformative Regimen

Phase 1 Intensive Peeling Masque (Day 1)

  • Professional application (45min)
  • Removed at home (4-7 hours later)

Phase 2 Resurfacing Moisturiser (4-6 weeks)

  • Home applications: 2-3 times daily
  • Day 1-6: flaking
  • Day 7-15: adjustment
  • Day 16-48: results peak

The Results

BEFORE
BEFORE
AFTER melanopro treatment
AFTER melanopro treatment
BEFORE
BEFORE
AFTER melanopro treatment
AFTER melanopro treatment
BEFORE
BEFORE
AFTER melanopro treatment
AFTER melanopro treatment
Dr Russell Wong
Dr Russell Wong

‘Melanopro Peel System has been developed and thoroughly tested to provide excellent results on all skin tones. I have witnessed outstanding outcomes on Fitzpatrick types one to three. However, it was particularly exciting to observe the results on Fitzpatrick types four to six, which are more susceptible to post-inflammatory hyperpigmentation and have limited treatment options.

Moreover, Melanopro Peel System is a comfortable treatment option with minimal to no downtime, so it does not disrupt the patient’s daily life.’
Dr Russell Wong, Dermatologist, Edmonton, Canada

For more information, visit dermalogica.com.au/pro

* Results from clinical study conducted on 30 subjects. Supplied by Dermalogica.

Previous articleIntroducing EMFACE® Submentum by BTL
Next articleElevating cosmetic and skin treatment standards: Embracing contemporary laser safety recommendations